From GlobeNewswire: 2025-05-30 09:02:00

The global proteomics market is on the rise, driven by applications in precision medicine and protein-based diagnostics. With the market expected to reach $85.91 billion by 2031, technological advancements in mass spectrometry and next-gen sequencing are transforming disease diagnosis and treatment. Proteomics plays a crucial role in personalized medicine, identifying protein biomarkers for targeted therapies and drug discovery.

The proteomics market is segmented by product & service, application, and end user, with reagents & consumables leading the market share. North America currently dominates the market, but Asia Pacific is projected to see the highest growth. Key players like Thermo Fisher Scientific and Illumina are driving innovation in proteomics, with a focus on advancements in AI, mRNA vaccines, and consumables for proteomics research.

Recent developments in proteomics include collaborations between industry leaders like SomaLogic and Illumina, aiming to enhance high-throughput sequencing platforms. The UK Biobank has launched a study analyzing proteins in the body to revolutionize disease research. Proteomics International received funding for clinical diagnostics, while Akoya Biosciences and Enable Medicine are creating a single-cell spatial proteomics atlas.

The rise of precision medicine and collaborations among pharmaceutical companies and technology providers are shaping the future of proteomics research and commercialization. The report from The Insight Partners offers valuable insights for stakeholders navigating the evolving market landscape, unlocking new opportunities for growth in proteomics research and development.



Read more at GlobeNewswire: Proteomics Market Size Significant Growth, expected to